Drug Profile
Opipramol
Alternative Names: Ensidon; G 33040; Insidon; NisidanaLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Novartis
- Developer Novartis; Sun Pharmaceutical Industries
- Class Dibenzazepines; Small molecules; Tricyclic antidepressants
- Mechanism of Action Dopamine D2 receptor antagonists; Histamine H1 receptor antagonists; Opioid receptor agonists; Serotonin 5-HT2 receptor antagonists; Sigma-1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Major depressive disorder
- Registered Generalised anxiety disorder
- No development reported Somatoform disorders